Shivani Mehta is a BS/BA candidate (2018) in public health at the Johns Hopkins Krieger School of Arts and Sciences, who is working with Drs. On September 5, CCGHE Director Dr. Robert C. Bollinger was installed as the inaugural recipient of the Raj and Kamla Gupta Professorship in Infectious Diseases, funded by the Ujala Foundation. See the complete profile on LinkedIn and discover Dr Amita’s connections and jobs at similar companies. Dr. Amita Gupta, MD is a Internal Medicine Specialist in Chandler, AZ and has over 31 years of experience in the medical field. October 30-November... Naik SN , Chandanwale A, Kadam D, Sambarey PW, Dhumal G, DeLuca A, Jain D, Gupta A, Bollinger R, Mave V. Does treatment of infertile women with probable genital tuberculosis improve fertility outcome? Naik S, Alexander M, Kumar P, Kulkarni V, Yadana S, Bhosale R, Babu S, Gupta A, Mathad J and Shivakoti R. Systemic inflammation in pregnant women with and without latent tuberculosis infection. Prar Vasudevan is an international health graduate student at the Johns Hopkins School of Public Health. Performance of QuantiFERON-TB Gold in Tube (QFT-GIT) and QuantiFERON-TB Gold Plus (QFT-Plus) for detection of Mycobacterium tuberculosis infection in pregnant women in India. Potential differences in systemic inflammation by LTBI status has not been assess in pregnant women. https://www.jhsph.edu/faculty/directory/profile/2372/amita-gupta The delayed diagnosis of tuberculous meningitis (TBM) leads to poor outcomes, yet the current diagnostic methods for identifying Mycobacterium tuberculosis in cerebrospinal fluid (CSF) are inadequate. quality medicines etc. Visit this medical health centre for … We validate a food frequency questionnaire (FFQ), New-Interactive Nutrition Assistant-... International Journal of Tuberculosis and Lung Disease. I am working as an Associate Professor & Unit Incharge since 2009 in the Department of Obstetrics & Gynecology at B.J.Govt Medical College & Sassoon General Hospitals Pune. Dr.Amita Gupta, a well-reputed Gynaecologist, practices in New Delhi. Background: The use of rifamycin antibiotics for TB prevention carries a risk of detrimental drug-drug interactions with concomitantly used ART. Diagnosis of TB among... New study launched in India & South Africa to identify functional relationships between genomics & metabolomics, & to characterize fundamental biological systems underlying resistance to Mtb infection. His research focuses on the diagnosis of acute febrile illness and its implication on antimicrobial stewardship and resistance in tropical low- and middle-income countries. I was immediately struck by the fact... Dr. Jessica Elf was a post doctoral fellow in the Department of International Health at the Johns Hopkins School of Public Health. Factors associated with gestational diabetes in HIV+ and HIV- women in Pune, India, Geographic and Individual Risk Factors for TB or Death in the Brief-TB Trial (A5279), Adjusted analysis of effect of IPT on adverse pregnancy outcomes in women with HIV, Tuberculosis preventive therapy should be considered for all household contacts of pulmonary TB patients in India, Increased moxifloxacin dosing among MDR-TB patients with low-level resistance to moxifloxacin did not improve treatment outcomes in a tertiary care centre in Mumbai, India, Performance of QuantiFERON-TB Gold in Tube (QFT-GIT) and QuantiFERON-TB Gold Plus (QFT-Plus) for detection of Mycobacterium tuberculosis infection in pregnant women in India, Six-week culture conversion predicts tuberculosis treatment outcomes, Association of latent TB infection in pregnancy with perinatal health outcomes in an Indian cohort. Infectious Disease News caught up with Dr. Amita Gupta at CROI 2019 to talk about TB prevention among people living with HIV, Staff and nearly 140 participants in the REPRIEVE study gathered for a community event in Pune, India. About 2 billion people worldwide harbor asymptomatic latent TB infection (LTBI), activation of which results in progression to TB disease. This study is investigating the immediate impact of the COVID-19 pandemic on mental health outcomes and overall quality of life and what are the factors associated with it among Indian Health care workers. Presented at: CROI... Chebrolu P , Alexander M, Bhosale R, Naik S, Patil N, Gupta A, Mathad J. She also supported provides the CTRIUMPh substudy entitled “Residual Respiratory Impairment Following Pulmonary TB” and the study entitled “Antimicrobial Use and Diagnosis among Hospitalized Febrile Patients.”. Dr. Amita Gupta. Get detailed info on consultation fee, OPD schedule, patients feedback, address and … Methods: A novel... Introduction: Globally, India has the third largest population of people living with HIV (PLHIV) and the second highest number of COVID-19 cases. Dr Amita has 3 jobs listed on their profile. The overall goal is to reduce TB incidence among (1) people living with HIV who are on antiretroviral therapy, and... Objectives/Aims We will compare the degree of lung impairment between HIV-TB co-infected adults (HIV-TB group) and TB cases without HIV co-infection (TB group) who successfully complete TB therapy. CTRIUMPh, funded by the US NIH and Indian Department of Biotechnology, is an academic collaboration between Johns Hopkins... Dr. Amita Gupta is Protocol Co-chair for this multinational clinical trial. Find Dr. Gupta's address, insurance information, hospital affiliations and more. 51st Union World Conference on Lung Health... Mathad J, Bhosale R, Barreto-Duarte B, Alexander M, Kulkarni V, Nathella PK, Andrade B, Gupta A. Polyfunctional T-cells and IL-2 production decrease in pregnant women with latent TB. Nikhil Gupta and Nishi Suryavanshi are leading this survey project. Boston,... Paradkar M, Chandrasekara P, Jain D, Shivakumar SVBY, Thiruvengadan K, Gupte AN, Thomas B, Kinikar A, Sekar K, Bharadwaj R, Dolla CK, Gaikwad S, Elilarasi S, Lokhande R, Reddy D, Murali L, Kulkarni V, Pradhan N, Hanna LE, Pattabiraman S, Kohli R, Nayagam R, Suryavanshi N, Shrinivasa BM, Cox SR,... Tornheim JA , Gajjar I, Shivakumar SVBY, Gupte AN, Kishore G, Karane M, Rodrigues C, Gupta A, Udwadia ZF. She has joined Dr. Amita Gupta’s lab and will be studying host biomarkers of HIV/TB and TB outcomes with particular interest in understanding inflammation pathways, their impacts and potential therapies. Clinical Case Discussions and Video Conference Archive, Mental Health Outcomes among Health Care Professionals Involved in the Treatment and Care of COVID 19 Patients in India, Hybrid Trial for Alcohol Reduction among People with TB and HIV in India, Pregnancy Associated Immune Responses to Tuberculosis and HIV in India and South Africa (PARTHISA), Increasing Market and Public Health Outcomes Through Scaling Up Affordable Access Models of Short Course Preventive Therapy for TB (IMPAACT4TB), Markers of Lung Impairment in HIV-TB Coinfected Indian Adults, T Cell Biomarkers and T-regulatory Responses to Pediatric TB, Inflammasome Genetics and Tuberculosis Treatment Outcomes, Evaluation of a Urinary Biomarker Assay for Diagnosis and Test of Cure for Tuberculosis, A5300B/I2003B: Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx), Management of Multidrug-resistant Tuberculosis among ART Programs in Low- and Middle-income Countries within the Global IeDEA Network, Visual Field Loss in HIV-Positive Patients of Non-Infectious HIV Retinopathy, Immune Correlates of LTBI in HIV-exposed Infants, Prevalence of Tuberculosis in Severely Malnourished Indian Children, Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but Resistant to MTB Infection, Host RNA Expression for Diagnosis and Monitoring of Pediatric TB in Africa and India, Immune Responses and Effect of Disulfiram on MTB Infected PBMCs as a Potential Host Directed Therapy, Characterization of TB-specific T Cell Responses in Highly-exposed, but Uninfected Health Care Workers in India, Vaginal Microbiota in HIV Infected and Uninfected Pregnant Women (Stand Alone), Systemic Inflammation in Pregnant Women With Latent Tuberculosis Infection, Higher interleukin-6 levels and changes in transforming growth factor-β are associated with lung impairment in pulmonary tuberculosis, Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine, Higher IL-6 Levels and Changes in TGF-β are Associated with Lung Impairment in Pulmonary Tuberculosis, Validation of NINA-DISH food frequency questionnaire with multiple 24-hour dietary recalls among pregnant women in Pune, India, Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes, Association of Vegetable and Animal Flesh Intake with Inflammation in Pregnant Women from India, Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention, Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward, Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women, Assessment of persistent depression among TB patients, The burden of anxiety among people living with HIV during the COVID-19 pandemic in Pune, India, Open Letter by Epidemic Intelligence Service Officers Past and Present - in Support of CDC, Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV, The Impact of Hypertension and Use of Calcium Channel Blockers on Tuberculosis Treatment Outcomes, Patient Trajectories Among Persons Hospitalized for COVID-19: A Cohort Study, Mental health and quality of life among healthcare professionals during the COVID-19 pandemic in India, Pharmacokinetics and drug-drug interactions of isoniazid and efavirenz in pregnant women living with HIV in high TB incidence settings: importance of genotyping, Reservoirs of transmission of resistant Gram-negative pathogens responsible for neonatal sepsis among hospitalized neonates in Pune, India, Screening for Tuberculosis (TB) in pregnant and non-pregnant women of reproductive age: Findings from an observational study in Pune, India, An RNA signature for TB risk in pregnant women: A prospective cohort study from India, Systemic inflammation in pregnant women with and without latent tuberculosis infection, Self-clearance of Mtb infection: needs and consequences, Polyfunctional T-cells and IL-2 production decrease in pregnant women with latent TB, Blood-based biomarkers of tuberculosis in children integrating metabolomic and transcriptomic data, Risk Factors for Hepatotoxicity in HIV-infected Women Receiving Isoniazid preventive Therapy in Pregnancy and Postpartum, Prevalence and Incidence of Tuberculosis Infection and Disease Among Household Contacts Exposed to Rifampin-resistant/Multidrug resistant Tuberculosis (RR/MDR-TB), Rifapentine pharmacokinetics and safety in pregnant women with and without HIV on 3HP. I am happy and i would recommend. Rifapentine pharmacokinetics and safety in pregnant women with and without HIV on 3HP. Dr. Gupta has rich experience of more than 20 years to her credit working with reputed Institutes such as Lok Nayak and Safdarjung Hospital. Ms. Mehta spent June and July 2016 at BJGMC in Pune, India, working under Dr. Alexander. She works in Sterling Heights, MI and specializes in Internal Medicine. October 20, 2020. Dr. Gupta is affiliated with St John Macomb-Oakland Hospital Warren Campus, Beaumont Hospital Troy and St Joseph Mercy Ypsilanti. Mandar Paradkar and Robert Bollinger are quoted in this article that highlights their recent paper about administration of TB preventive therapy for household contacts of confirmed TB cases in India. She serves in leadership positions as Center Director for the Johns Hopkins Precision Medicine Center for Excellence for COVID-19, the US chair for the Indo-US Vaccine Action Program sponsored RePORT India TB research consortium, which is funded by the US National Institutes of Health (NIH) and the government of India, Department of Biotechnology. Dr. Amita Gupta is an Internal Medicine Specialist in Sterling Heights, Michigan. Adequate dietary intake is critical to prevent adverse pregnancy outcomes. 51st Union World Conference on Lung Health. She is accepting new patients. Harsh Gupta, MD is a board certified Gastroenterology with Amita offices located in Evanston, IL. BACKGROUND The World Health Organization (WHO) estimates that there were 480,000 incident cases of MDR-TB globally in 2015. Q: What is Dr. Amita Gupta's education qualification? Macomb Physicians Group PLLC . Dr. Amita Gupta, MD is a Internal Medicine Specialist in Sterling Heights, MI and has over 29 years of experience in the medical field. View Dr Amita Gupta’s profile on LinkedIn, the world’s largest professional community. Predictors of tuberculosis infection in MDR-TB household contacts ≥15 years old. Dr. Gupta is affiliated with St John Macomb-Oakland Hospital Warren Campus, Beaumont Hospital Troy and St Joseph Mercy Ypsilanti. Dr. Amita Gupta is a Infectious Disease Specialist in Baltimore, MD. Dr. Amita Gupta practices at Kalpavriksh Super Speciality Center in Dwarka, Delhi and Bensups Hospital in Dwarka, Delhi. The immunologic conditions responsible for this phenomenon are not... Primary Objective: This study is being conducted in Brazil, Cambodia, China, Ethiopia, Ghana, Haiti, India, Indonesia, Kenya, Malawi, Mozambique, South Africa, Tanzania, and Zimbabwe. Dr. Amita Gupta is a Gynecologist in Jankipuram Extension. We are leveraging the RePORT platform by including a cohort of Indian children together with South African children in a large validation study to study on changes in gene expression profiles during treatment for TB. I am working as associate professor in orthopedics. He completed a joint MD/MPH at Mount Sinai School of Medicine, with his thesis evaluating the impact of water... Matthew Robinson, MD, is a research fellow in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. October 20-24, 2020. Dr. Gupta graduated from the Lady Hardinge Medical College,Lady Hardinge Med Coll Delhi Univ in 1990. She cares for patients with infections that are difficult to diagnose and treat, and can be life-threatening. STUDY DESIGN We will conduct a retrospective case-cohort study nested within the CTRIUMPH and EDOTS cohorts to address our study objectives. October 20, 2020. Methods: This... Risk factors for progression of coronavirus 2019 (COVID-19) to severe disease or death are underexplored in U.S. cohorts. Akshay Gupte is a junior investigator trained in medicine, clinical research, and global health. Having completed her post-graduation in Dermatology, Venereology (including HIV) and Leprology from this premier institute, she has acquired clinical skills as well as an affinity for research. Book appointments Online, View Fees, User Feedbacks for Dr. Amita Gupta | Practo Reservoirs of transmission of resistant Gram-negative pathogens... Alexander M, Bhosale R, Naik S, Kulkarni V, Mave V, Suryavanshi N, Gupte N, Gupta A, Mathad J. Her specialties include Internal Medicine. This study is funded and conducted under the U.S. National Institutes of Health, Fogarty International Center. Email: ccghe@ccghe.net. Dr. Amita Gupta Gynaecologist Appointment , Online Consultation Dr. Amita Gupta Gynaecologist Delhi India, Dr. Amita Gupta Rockland Hospital Delhi, Dr. Amita Gupta Fees, Dr. Amita Gupta Review, Dr. Amita Gupta Email ID, Dr. Amita Gupta Contact No, Dr. Amita Gupta Whatsapp No. 600 N. Wolfe Street Sonya Krishnan, MD, is a clinical fellow in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. Email: agupta25@jhmi.edu. TB Science 2020. After completing undergraduate studies in International Development and Economics at Brandeis University he moved to East Africa where he engaged in health system strengthening for returning refugees to South Sudan and worked with the Centers for Disease Control and Prevention (CDC) on the epidemiology of pneumonia and diarrhea in Western Kenya. Dr. Krishnan grew up in Minnesota and completed her undergraduate studies at Carleton... Johns Hopkins ID Insider: Dr. Gupta: "I chose infectious diseases as a career because I found it to be the most embracing of diversity, and it really nicely combines my interest in medicine, social justice, public health and global affairs. Find Dr. Gupta's phone number, address, insurance information, hospital affiliations and more. Her primary research focus was on the epidemiology and health impacts of tobacco use and exposure to indoor air pollution from the combustion of biomass fuels. Ms. Tharmarajah is a 2015 recipient of the Global Health Established Field Placement Grant. The first comparative study of the new GeneXpert MTB/RIF Ultra (Xpert Ultra) for TBM diagnosis... Background: Tuberculosis (TB) preventive therapy (TPT) among pregnant women reduces the risk of TB in mothers and infants, but the timing of initiation should consider potential adverse effects. The highest incidence of tuberculosis disease (TB) in the world is in India, accounting for 27% of all new cases globally, with approximately 86,000 among persons with HIV (PWH). Medicines started causing irritation at private parts. October 20-24, 2020. A: Patients frequently visit Dr. Amita Gupta for Health Checkup (General), Female Disorder, Normal Vaginal Delivery (NVD). This will enable us to measure the association of polymorphisms with multiple clinical outcomes simultaneously and... Dr. Jeff Tornheim is PI of this study. Methods: We conducted a... Higher levels of IL-6 and slow-to-resolve TGF-β are associated with lung impairment in treated tuberculosis. See the complete profile on LinkedIn and discover Dr Amita’s connections and jobs at similar companies. Predictors of tuberculosis infection in MDR-TB household contacts ≥15 years old. Purpose: Tuberculosis (TB) is a leading cause of maternal mortality, especially among HIV-infected women. March 8-11, 2020. Adjusted analysis of effect of IPT on adverse pregnancy outcomes in women with HIV. Virtual. Matthew Murrill is an MD-PhD student in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. Phipps 521 October 30-... Matthew Robinson, MD, is Assistant Professor in the Division of Infectious Diseases at Johns Hopkins University School of Medicine, and he serves on the Advisory Team for the and serves on the Advisory Team for the Johns Hopkins Precision Medicine Center of Excellence for COVID-19. He is working with Drs. Background: The COVID-19 pandemic has placed healthcare professionals (HCP) in stressful circumstances with increased patient loads and a high risk of exposure. In 2016, he was named an IDSA Education and Research Foundation Medical Scholar. His research interests include exploring approaches to host directed adjuvant therapies in tuberculosis (TB) and studying the impact of TB and HIV on lung health of populations. She is Co-chair of the NIH and AmFAR funded IeDea HIV/TB Working Group and Scientific Committee co-Chair for IMPAACT TB. PIs are Robert Bollinger, MD, MPH; Dr. Muralidhar Tambe, BJGMC Severely malnourished children are vulnerable population for communicable and non-communicable disease. 50th Union World... Kulkarni V , Bhosale R, Jain D, Deshpande P, Naik N, Alexander M, Patil N, Gupte N, Gupta A, Mathad J. Blood-based biomarkers of tuberculosis in children integrating metabolomic and transcriptomic data. Vipan Gupta, MD is a board certified Neurology with Amita offices located in Schaumburg, IL. In Autumn 2015, she conducted a field placement in Pune, India, at BJGMC under Dr. Vidya Mave, where she worked on the study titled Maternal Inflammation, Diet and Gut Microbiome in HIV: Impact on Infant Outcomes. Macomb Physicians Group PLLC . STUDY DESIGN We will conduct a retrospective case-cohort study nested within the CTRIUMPH and EDOTS cohorts to address our study objectives. Gupta A. Self-clearance of Mtb infection: needs and consequences. Dr Amita has 1 job listed on their profile. Dr. Amita Gupta, MD is an infectious disease specialist in Baltimore, Maryland. She visited BJGMC from June 18, 2018, to August 11, 2018, to provide support to the BJGMC Clinical Research Site. A: You can take Dr. Amita Gupta's appointment online through Practo for in-clinic visit or for video consultation with the doctor. Presented at: CROI 2020. Dr. Amita Gupta, MD is a board certified internist in Sterling Heights, Michigan. Prevalence and Incidence of Tuberculosis Infection and Disease Among Household Contacts Exposed to... Mathad JS , Savic RM, Britto P, Wiesner L, Townley E, Chakhtoura N, Bradford S, Patil S, Vhembo T, Lespinasse D, Langat D, Werarak P, Kamthunzi P, Gupta A, Dooley KE. You can, MBBS - Baba Raghavdas Medical College, Gorakhpur, 1995, DGO - King Georges Medical College, Lucknow University, 1998, 2000 - 2003 Consultant at Fatima Hospital, 2003 - Present Consultant at Matra Drishti Medicare, 39969 Uttar Pradesh Medical Council, 1995, Doctors For Anxiety Disorders TreatmentDepression Treatment in Lucknow, Doctors For Constipation Treatment in Lucknow, Doctors For General DentistryLaminates in Lucknow, Doctors For Depression TreatmentDyslipidemia in Lucknow, Doctors For Kidney Stone Treatment in Lucknow, Doctors For Chickenpox Treatment in Lucknow. Dr. Amita Gupta is a Gynecologist in Jankipuram Extension. Calcium channel blockers (CCB) improve TB treatment outcomes in pre-clinical models, but their effect in patients with TB remain unclear. Make an Appointment + Locations, Office Hours & Directions. 125 honorees were selected for their outstanding dedication to Hopkins' core values; CCGHE's Amita Gupta and Kathleen Page were among them. During June-July 2015, she conducted a field study placement at the National Institute of Research in Tuberculosis in Chennai, India, where she worked on the C-TRIUMPH lung health substudy. Dr. Amita Gupta is a Infectious Disease Specialist in Baltimore, MD. It may be other reason for that.......and without any reason u can't defame the doctor......is fee of 500 can built castles....... Dr. Amita Gupta practices at Matra Drishti Medi Care - Jankipuram Extension. Dr. Amita Gupta is a Co-PI on this study. Harsh Gupta, MD is a board certified Gastroenterology with Amita offices located in Evanston, IL. Presented at: CROI 2020. Dr. Gupta is Deputy Director of the Johns Hopkins (JH) Center for Clinical Global Health Education (CCGHE), and Professor of Infectious Diseases at the JH School of Medicine, with a joint appointment in International Health at the JH Bloomberg School of Public Health. Her credentials are: MD (Doctor of Medicine).She lists the following medical group affiliations: Ravi Gupta, Md, Pllc.Her hospital privileges include: Banner Baywood Medical Center, Banner Heart Hospital, Mercy Gilbert Medical Center. Dr Amita has 3 jobs listed on their profile. View Dr Amita Gupta’s profile on LinkedIn, the world’s largest professional community. Hyderabad, India. Prof./Dr./Mr./Ms. Poster presentation. Hyderabad, India. Virtual Conference. You can read detailed reviews of the doctor on Practo. Factors associated with gestational diabetes in HIV+ and HIV- women in Pune, India. INTRODUCTION: Testing for anti-TB drugs in small hair samples may serve as a non-invasive tool to measure cumulative drug exposure and/or adherence, as these determine treatment success. Virtual. Johns Hopkins School of Medicine Find location information or contact Dr. Amita Gupta here. Book appointments Online, View Fees, User Feedbacks for Dr. Amita Gupta | Practo To see more reasons visit the, Dr. Amita Gupta has been recommended by 13 patients and has recieved stories from 5 patients. Accompanied the Deputy Director of the Division of AIDS, the Associate Director of International Health Programs, NIAID and other NIH delegates on site visits to 15 Indian institutions throughout the country, 2011-2012: Selected to participate in the Johns Hopkins School of Medicine’s Office in Science and Medicine (OWISM) Leadership Program for Women Faculty, 2012-present: Member, ACTG TB Transformative Science Group, 2014-present: IMPAACT TB Scientific Committee Vice-Chair, 2014-present: Co-investigator IMPAACT 2001 Protocol Team, PK and Safety of INH and Rifapentine in Pregnancy, 2014-2016: US Co-chair, NIH-India Government, Regional Prospective Observational Research in Tuberculosis (RePORT), 2014-present: Co-chair PHOENIX ACTG A5300/IMPAACT 2003 feasibility study and MDR TB contact prophylaxis trial, 2016-present: US Chair, TB Research Consortium, RePORT India, 2016-present: Member, Executive Committee, RePORT International, 2017: Selected to participate in the Johns Hopkins Leadership Development Program (LDP), 2015-present: Member, Union Interest Group in Maternal-Infant TB working group, 2018: Participant, Technical Consultation on Advances in Clinical Trial Design for Development of New TB Treatments, WHO Report generation, 2018-present: co Chair, IeDEA TB working group, 2020-present: Governing Board Member, Indo-US Science and Technology Forum (IUSTTF), 2020-present: Chair, Faculty Steering Committee, Johns Hopkins India Institute, 2020-present: Center Director, Johns Hopkins Precision Medicine Center for Excellence for COVID-19. She speaks English, Spanish. Poster Presentation. Initiating 28-week isoniazid therapy during pregnancy was noninferior to initiating it 12 weeks after delivery to prevent tuberculosis in pregnant women with HIV who are on ART. 50th Union World Conference on Lung Health. The doctor also provides online video consultation through Practo. Graham H , Bhosale R, Alexander M, Kinikar A, Khwaja S, Patil N, Mathad J, Shivakoti S, Gupta A. She graduated from Lady Hardinge Medical College, University Of Delhi medical school in 1990. Dr. Amita Gupta is a Gynaecologist in Medeor Hospital Dwarka, New Delhi. Drs. His research focuses on the diagnosis of acute febrile illness and its implication on antimicrobial stewardship and resistance in tropical low- and middle-income countries. After completing undergraduate studies in chemistry at Maryville College, he moved to Kolkata, India, as a Fulbright-Nehru fellow to research the sources and health effects of groundwater arsenic contamination in Eastern India with the School of Environmental Studies - Jadavpur University. During the 2020-2021 academic year she will also be pursing additional training via the Bloomberg School of Public Health’s Graduate Training Program In Clinical Investigation. Dr. Amita Gupta is a Co-PI on this study.